Bullet Points from the Proactive Video - Montef

Bullet Points from the Proactive Video

- Montefiore patients were very, very sick – and, amazingly, 4 survived
- However, after the Montefiore patients, 95% of patients are showing improvement
- In fact, there have been NO patient deaths after Montefiore patients
- In other words, the rate of survival with leronlimab is 100%
- Dr. Patterson found a protein in COVID that has not been talked about
- It is 100x the normal level in critical patients
- And it is 5x the normal level in mild to moderate patients
- That protein happens to be Rantes (CCL5)
- And Rantes is the specific target that leronlimab blocks
- Rantes is a like a magnet for immune cells
- There are high levels of Rantes found in the lungs, liver, and kidneys
- This explains the morbidity and mortality due to these end organ processes
- By blocking Rantes, leronlimab blocks the mass migration of immune cells which produce toxic cytokines that destroy lung tissue
- Leronlimab blocks this protein, it is the key to COVID, and it is a brand new discovery that nobody has ever talked about
- Leronlimab is the only drug in the world that quiets the cytokine storm, improves immunologic homeostasis, and decreases viral load
- No other drug can claim that
- Anthony Fauci said yesterday that the antiviral remdesivir would have to be combined with an anti-inflammatory that addresses the immunological problems
- Leronlimab is one drug that addresses the immunological issues and drops the viral load as if it was an antiviral
- We have figured out this disease

MY COMMENT: The paper will begin to be discussed tomorrow – and it is going to be big.